Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Moore

Showing results (1231-1240 of 1,262) with videos related to

Pageof 127
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
Addiction Science & Clinical Practice|March 19, 2024
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerationsBethany McLeman, Phoebe Gauthier, Laurie S Lester, et al.
Scientific Reports|October 23, 2015
Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injuryA D B Vliegenthart, J M Shaffer, J I Clarke, et al.
Emerging Infectious Diseases|February 22, 2019
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant TuberculosisMuhammad Osman, Elizabeth P Harausz, Anthony J Garcia-Prats, et al.
The Journal of Experimental Medicine|October 7, 2021
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastropheGuoxin Zhang, Zhen Dong, Ryan C Gimple, et al.
Journal of Substance Use and Addiction Treatment|May 19, 2026
"We need to keep in mind that battle fatigue": A commentary on moral injury among substance use treatment and community service providersElizabeth C Saunders, Bethany McLeman, Lisa A Marsch, et al.
Journal of Proteome Research|February 1, 2019
Progress and Challenges in Ocean Metaproteomics and Proposed Best Practices for Data SharingMak A Saito, Erin M Bertrand, Megan E Duffy, et al.
Journal of Clinical Medicine|February 27, 2026
Prevalence of Futility Protocols for Severely Bleeding Trauma Patients: A Survey from the Association for the Advancement of Blood & Biotherapies (AABB)Samuel J Thomas, Dan A Waxman, Daniela Hermelin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521William A Hall, Theodore G Karrison, Seth A Rosenthal, et al.
Journal of Substance Use and Addiction Treatment|May 3, 2026
The community representative council of the National Drug Abuse Treatment Clinical Trials Network: Co-design and early impactSarah K Moore, Bethany McLeman, Elizabeth C Saunders, et al.
Pageof 127

Showing results (1231-1240 of 1,262) with videos related to

Sort By:
Pageof 127
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
Addiction Science & Clinical Practice|March 19, 2024
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerationsBethany McLeman, Phoebe Gauthier, Laurie S Lester, et al.
Scientific Reports|October 23, 2015
Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injuryA D B Vliegenthart, J M Shaffer, J I Clarke, et al.
Emerging Infectious Diseases|February 22, 2019
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant TuberculosisMuhammad Osman, Elizabeth P Harausz, Anthony J Garcia-Prats, et al.
The Journal of Experimental Medicine|October 7, 2021
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastropheGuoxin Zhang, Zhen Dong, Ryan C Gimple, et al.
Journal of Substance Use and Addiction Treatment|May 19, 2026
"We need to keep in mind that battle fatigue": A commentary on moral injury among substance use treatment and community service providersElizabeth C Saunders, Bethany McLeman, Lisa A Marsch, et al.
Journal of Proteome Research|February 1, 2019
Progress and Challenges in Ocean Metaproteomics and Proposed Best Practices for Data SharingMak A Saito, Erin M Bertrand, Megan E Duffy, et al.
Journal of Clinical Medicine|February 27, 2026
Prevalence of Futility Protocols for Severely Bleeding Trauma Patients: A Survey from the Association for the Advancement of Blood & Biotherapies (AABB)Samuel J Thomas, Dan A Waxman, Daniela Hermelin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521William A Hall, Theodore G Karrison, Seth A Rosenthal, et al.
Journal of Substance Use and Addiction Treatment|May 3, 2026
The community representative council of the National Drug Abuse Treatment Clinical Trials Network: Co-design and early impactSarah K Moore, Bethany McLeman, Elizabeth C Saunders, et al.
Pageof 127